Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Submitted by
admin
on October 7, 2009 - 8:40am
Source:
Bloomberg
News Tags:
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Headline:
Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Do Not Allow Advertisers to Use My Personal information
